payers

How Payers Are Reacting to Insulin Price Changes
How Payers Are Reacting to Insulin Price Changes
Drug Channels
payers
insurance
insulin
diabetes
drug pricing
Inflation Reduction Act
Medicare
Flag link:
Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance
Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance
MedCity News
insurance
weight loss
payers
Novo Nordisk
Eli Lilly
Flag link:
As government funding dries up, Pfizer expects to charge private payers $110+ for Covid-19 vaccine
As government funding dries up, Pfizer expects to charge private payers $110+ for Covid-19 vaccine
Endpoints
Pfizer
BioNTech
payers
vaccines
COVID-19
Flag link:
Medicare is using one of its biggest hammers to try to fix the dialysis system: how providers are paid
Medicare is using one of its biggest hammers to try to fix the dialysis system: how providers are paid
Stat
dialysis
chronic kidney disease
Medicare
payers
Flag link:
‘Some way to go’ before decision on Biogen Alzheimer’s drug, says UnitedHealth
‘Some way to go’ before decision on Biogen Alzheimer’s drug, says UnitedHealth
Biopharma Reporter
Unitedhealth Group
Biogen
Aduhelm
payers
Alzheimer's disease
Flag link:
Anthem, Humana join hedge fund to launch PBM
Anthem, Humana join hedge fund to launch PBM
MedCity News
PBMs
payers
Anthem
Humana
hedge funds
DomaniRx
Flag link:
Supreme Court upholds ACA, dismissing constitutional challenge
Supreme Court upholds ACA, dismissing constitutional challenge
MedCity News
Supreme Court
healthcare reform
Affordable Care Act
payers
Flag link:
CVS drug buyers say pharmacy overcharged them $100M as trial opens
CVS drug buyers say pharmacy overcharged them $100M as trial opens
MedCity News
drug pricing
CVS Health
legal
payers
Flag link:
Countering payers, drugmakers say net prices declined in 2020
Countering payers, drugmakers say net prices declined in 2020
BioPharma Dive
drug pricing
payers
Flag link:
Report: 10M could lose insurance by the end of 2020
Report: 10M could lose insurance by the end of 2020
MedCity News
payers
insurance
pandemic
COVID-19
Urban Institute
Flag link:
Why People With MS Need Permission from Insurers To Take Life-Saving Drugs. It’s Not The Reason You Think.
Why People With MS Need Permission from Insurers To Take Life-Saving Drugs. It’s Not The Reason You Think.
Forbes
MS
multiple sclerosis
patients
insurers
payers
drug pricing
Flag link:
Zolgensma hits the ground running, says Novartis
Zolgensma hits the ground running, says Novartis
Pharmaforum
Novartis
Zolgensma
AveXis
SMA
payers
Flag link:
J&J scores Spravato trial win in high-risk depression. Will doctors and payers buy in?
J&J scores Spravato trial win in high-risk depression. Will doctors and payers buy in?
Fierce Pharma
JNJ
clinical depression
high-risk depression
Spravato
physicians
payers
Flag link:
Revealing the true value of new cancer drugs to payers
Revealing the true value of new cancer drugs to payers
Pharmaforum
CAR-T
cancer
payers
Flag link:
24 insurers have policies on coverage of world's most expensive drug
24 insurers have policies on coverage of world's most expensive drug
Beckers Hospital Review
Novartis
payers
insurance
Medicaid
SMA
drug pricing
Zolgensma
Flag link:
"Smart Pill" Schizophrenia Drug Unlikely To Move Payers
"Smart Pill" Schizophrenia Drug Unlikely To Move Payers
Forbes
Otsuka
Abilify MyCite
smart pills
schizophrenia
payers
Flag link:
Payers, patients coming on board for Novartis’ Zolgensma
Payers, patients coming on board for Novartis’ Zolgensma
BioCentury
Novartis
Zolgensma
SMA
gene therapy
payers
patients
Flag link:
White House pulls drug rebate rule to relief of payers
White House pulls drug rebate rule to relief of payers
Biopharma Dive
payers
drug rebates
Medicaid
Medicare
PBMs
Flag link:
Novartis struggling to win payer coverage for $2.1M gene therapy Zolgensma: analysts
Novartis struggling to win payer coverage for $2.1M gene therapy Zolgensma: analysts
Fierce Pharma
Novartis
Zolgensma
drug pricing
SMA
gene therapy
payers
Flag link:
Time to fix pharma’s outdated business model
Time to fix pharma’s outdated business model
Pharmaforum
pharma industry
payers
patients
Janssen
Flag link:

Pages